CRMD CorMedix Inc.
$8.00▲ +0.76%
Healthcare
Other
Volume 1.00M
Avg Volume (10D) 1.13M
Key Metrics & Fundamentals
Market Cap
$623.55M
P/E Ratio
3.9
Div Yield
0.00%
52W Range
6.13 - 13.02
% vs 50 MA
1.71%
% vs 200 MA
4.28%
RSI-14
59.4
MACD Histogram
+0.0900
Beta (1Y vs SPY)
1.02
Free Cash Flow
$85.68M
Gross Rev
$99.31M
Gross Profit
$74.50M
EBITDA
$57.56M
COGS
$24.81M
Operating Exp
$31.59M
Operating Income
$42.91M
EBIT
$42.91M
Pretax Income
$38.73M
Net Income
$25.99M
EPS (Diluted)
0.29
Price & Volume History
Loading chart…
Recent News
CorMedix Receives FDA Priority Review for Rezzayo Fungal Disease Prevention
MT Newswires · Oct 19, 2026 8:48 AM ET
Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
GlobeNewswire · Oct 19, 2026 7:30 AM ET
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
PR Newswire · Oct 15, 2026 7:30 AM ET
CRMD vs. PRTA: Which Stock Should Value Investors Buy Now?
Zacks · Oct 8, 2026 10:40 AM ET
Oppenheimer Initiates CorMedix at Outperform With $15 Price Target
MT Newswires · Sep 23, 2026 6:38 AM ET
CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged
Insider Monkey · Sep 7, 2026 10:45 PM ET
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet
Zacks · Sep 7, 2026 9:55 AM ET
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
GlobeNewswire · Sep 1, 2026 8:30 AM ET
CorMedix (CRMD) Upgraded to Buy: Here's Why
Zacks · Aug 31, 2026 12:00 PM ET
CorMedix (CRMD) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 10:14 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CRMD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.